GGenetics Read More FDA Rejects CAPR’s Cell Therapy BLA for Genetic Disorder, Stock Tanks – July 14, 2025July 14, 2025 Key Takeaways CAPR’s BLA for deramiocel in DMD cardiomyopathy received an FDA complete response letter. The FDA cited…